MentalHealthDaily

Lisdexamfetamine (Vyvanse) Changes Brain Connectivity & Activation to Treat Binge Eating Disorder (2023 Study)

by GLOOM

Binge-eating disorder (BED), characterized by recurrent episodes of overeating without compensatory behaviors, is a significant global health concern. Lisdexamfetamine dimesylate (LDX), the only drug approved for moderate to severe BED, is showing promise not just in reducing episodes but also in altering brain function in ways previously not fully understood. Through a groundbreaking study, researchers …

Symptom Provocation in Psychiatric Disorders: TMS, EEG, Neural Circuits for Personalized Treatment (2023 Review)

by GLOOM

Symptom provocation, a cornerstone of psychiatric research and therapy, offers a fascinating glimpse into the intricate relationship between brain activity and psychiatric symptoms. By deliberately triggering symptoms, researchers and clinicians can identify neurophysiological biomarkers and target them with personalized therapies, such as transcranial magnetic stimulation (TMS). This technique not only enhances our understanding of psychiatric …